We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
-2.7%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$228M
AUM Growth
-$18.3M
Cap. Flow
-$9.44M
Cap. Flow %
-4.13%
Top 10 Hldgs %
58.67%
Holding
92
New
19
Increased
15
Reduced
21
Closed
24

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$2.65M
2
PYPL icon
PayPal
PYPL
+$1.2M
3
TSM icon
TSMC
TSM
+$1.05M
4
IBB icon
iShares Biotechnology ETF
IBB
+$912K
5
GLD icon
SPDR Gold Trust
GLD
+$877K

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$6.26M
2
AMGN icon
Amgen
AMGN
+$2.87M
3
VZ icon
Verizon
VZ
+$2.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$2.03M
5
INCY icon
Incyte
INCY
+$1.78M

Sector Composition

Rank Sector Weight
1 Healthcare 34.68%
2 Technology 11.59%
3 Communication Services 7.6%
4 Financials 4.91%
5 Consumer Discretionary 2.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQ icon
51
Equillium
EQ
$139M
$522K 0.23%
165,663
-22,003
-12% -$80.5K
KRE icon
52
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
$517K 0.23%
+7,500
New +$546K
MU icon
53
CALL
Micron Technology
MU
$930B
$506K 0.22%
+6,500
New +$554K
AMRN
54
Amarin Corp
AMRN
$298M
$494K 0.22%
7,500
-500
-6% -$33K
MU icon
55
PUT
Micron Technology
MU
$930B
$467K 0.2%
6,000
-4,000
-40% -$341K
OVID icon
56
Ovid Therapeutics
OVID
$414M
$445K 0.19%
141,701
– –
SOFI icon
57
SoFi Technologies
SOFI
$21B
$425K 0.19%
+45,000
New +$517K
KRE icon
58
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
$345K 0.15%
+5,000
New +$364K
CSCO icon
59
CALL
Cisco
CSCO
$457B
$279K 0.12%
+5,000
New +$283K
AIRT icon
60
Air T
AIRT
$75.5M
$273K 0.12%
12,000
+1,996
+20% +$48.3K
TBHC
61
DELISTED
The Brand House Collective
TBHC
$224K 0.1%
+24,132
New +$344K
APTX
62
DELISTED
Aptinyx Inc. Common Stock
APTX
$129K 0.06%
57,000
– –
PRTA icon
63
CALL
Prothena Corp
PRTA
$425M
$91K 0.04%
+2,500
New +$90.1K
LCTX icon
64
Lineage Cell Therapeutics
LCTX
$269M
$82K 0.04%
53,000
-32,000
-38% -$49.7K
NKTR icon
65
Nektar Therapeutics
NKTR
$2.39B
$81K 0.04%
1,000
-1,087
-52% -$161K
ET icon
66
CALL
Energy Transfer Partners
ET
$70.1B
$50K 0.02%
+4,500
New +$44.6K
IMDX
67
Insight Molecular Diagnostics
IMDX
$150M
$37K 0.02%
1,257
+650
+107% +$20.8K
AMGN icon
68
Amgen
AMGN
$208B
– –
-12,750
Closed -$2.87M
APTV icon
69
Aptiv
APTV
$12B
– –
-2,250
Closed -$371K
AZN icon
70
AstraZeneca
AZN
$263B
– –
-6,373
Closed -$742K
BDX icon
71
Becton Dickinson
BDX
$45.6B
– –
-2,050
Closed -$503K
BMY icon
72
Bristol-Myers Squibb
BMY
$133B
– –
-32,500
Closed -$2.03M
BOX icon
73
Box
BOX
$4.37B
– –
-18,500
Closed -$485K
FCX icon
74
Freeport-McMoran
FCX
$90B
– –
-10,000
Closed -$417K
HON icon
75
CALL
Honeywell
HON
$77B
– –
-9,549
Closed -$1.88M
1 2
3
4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, DCF Advisers held 92 positions worth $228M, down 7.4% from $247M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

DCF Advisers withdrew a net $9.44M in Q1 2022, closing 24 positions and reducing 21 holdings. Its most notable exit was Amgen, an estimated $2.87M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in Meta Platforms (Facebook) worth $2.36M.

  • DCF Advisers's largest Q1 2022 buy was Meta Platforms (Facebook): 10,600 shares worth $2.36M.
  • DCF Advisers added most to SPDR Gold Trust in Q1 2022, an estimated $877K increase.
  • DCF Advisers's biggest Q1 2022 reduction was Intra-Cellular Therapies Inc., cutting an estimated $6.26M.
  • DCF Advisers fully exited Amgen in Q1 2022, selling an estimated $2.87M.
  • DCF Advisers's ten largest holdings make up 59% of its $228M portfolio in Q1 2022.
  • DCF Advisers opened 19 new positions and closed 24 in Q1 2022.
  • DCF Advisers's portfolio value fell 7.4% quarter-over-quarter to $228M.

Based on DCF Advisers's 13F filing for Q1 2022, filed 13 May 2022.